Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Meningioma × vistusertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Meningioma 1 Endometrial Neoplasms 1 Carcinoma 1

Interventions

Tranexamic Acid 2 Radiotherapy 2 vistusertib 1 sintilimab 1 Verteporfin 1 Sensitivity Training Groups 1 Radiosurgery 1 Magnetic Resonance Spectroscopy 1 Immunoenzyme Techniques 1 Imatinib Mesylate 1 Hyperspectral Imaging 1 Hydroxyurea 1 Heavy Ion Radiotherapy 1 Gelclair 1 Chemotherapy, Adjuvant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03071874 2022-10-18

Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas

Massachusetts General Hospital

Phase 2 Unknown

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡